Artemis Medicare Services Ltd
Thu 13/03/2025,15:59:6 | NSE : ARTEMISMED
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 236.60
Previous Close
₹ 234.86
Volume
63321
Mkt Cap ( Rs. Cr)
₹3160.45
High
₹ 236.60
Low
₹ 225.35
52 Week High
₹ 350.00
52 Week Low
₹ 141.30
Book Value Per Share
₹ 57.59
Dividend Yield
0.19
Face Value
₹ 1.00
What’s Your Call?
Collective community sentiment on Artemis Medicare Services Ltd
Your Vote -
Buy
89.47%
Hold
5.26%
Sell
5.26%
89.47%
19 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
0%
Sell Order Quantity
100%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
229.68
788
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
788
Option Chain
Analyzes market sentiment, predicts Artemis Medicare Services Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Artemis Medicare - Updates
-
Artemis Medicare - Copy of Newspaper Publication
-
Artemis Medicare - Monitoring Agency Report
-
Artemis Medicare - Investor Presentation
-
Artemis Medicare - Press Release
-
Artemis Medicare - Updates
-
Artemis Medicare - Integrated Filing- Financial
-
Artemis Medicare - Integrated Filing (Financial)
-
Artemis Medicare - Statement of deviation(s) or variation(s) under Reg. 32
-
Artemis Medicare - Closure of operations
-
Artemis Medicare - Financial Result Updates
-
Artemis Medicare - Outcome of Board Meeting
-
Artemis Medicare - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Artemis Medicare - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Artemis Medicare - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Artemis Medicare - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulation
-
Artemis Medicare Q3 net profit jumps 80.54% at Rs 20.78 cr
-
Artemis Medicare - Statement Of Deviation Or Variation- Quarter Ended December 31, 2024
-
Artemis Medicare - Un-Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter/ Nine Months Perio
-
Artemis Medicare - Board Meeting Outcome for Board Meeting Held On February 5, 2025
-
Artemis Medicare - Board Meeting Intimation
-
Artemis Medicare - Board Meeting Intimation for Consideration Of Un-Audited Financial Results
-
Artemis Medicare - Closure of operations
-
Artemis Medicare - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Artemis Medicare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Artemis Medicare - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Artemis Medicare - Change in Director(s)
-
Artemis Medicare - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Artemis Medicare - Shareholders meeting
-
Artemis Medicare - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Artemis Medicare - Trading Window-XBRL
-
Artemis Medicare - Trading Window
-
Viewpoint Update: Artemis Medicare Services
-
Stock Update: Artemis Medicare Services
-
Artemis Medicare
-
Stock update – Artemis Medicare
-
Artemis Healthcare Services
-
Artemis Medicare
Key fundamentals
Evaluate the intrinsic value of Artemis Medicare Services Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 689.8418 | 630.3012 | 534.366 | 420.3905 | 385.528 |
| Liabilities | 689.8418 | 630.3012 | 534.366 | 420.3905 | 385.528 |
| Equity | 13.5861 | 13.4119 | 13.2377 | 13.2377 | 13.2377 |
| Gross Profit | 128.3782 | 93.7832 | 67.1723 | 35.0485 | 62.236 |
| Net Profit | 49.146 | 39.685 | 32.5774 | 7.0871 | 20.4283 |
| Cash From Operating Activities | 107.5927 | 129.3536 | 60.7119 | 27.2939 | 56.4858 |
| NPM(%) | 5.81 | 5.55 | 5.97 | 1.76 | 3.62 |
| Revenue | 845.2285 | 714.3311 | 544.784 | 402.0637 | 563.0909 |
| Expenses | 716.8503 | 620.5479 | 477.6117 | 367.0152 | 500.8549 |
| ROE(%) | 6.2 | 5 | 4.11 | 0.89 | 2.57 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 05 Jul 2024 | 0.45 | 45 | 0.2 | 178.7 |
Peers
Other companies within the same industry or sector that are comparable to Artemis Medicare Services Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 808.20 | -1.14 | 11.41 | 130.98 | 1321.50 | 1.42 |
| Lotus Eye Hospital and Institute Ltd | 57.06 | -0.77 | 237.75 | 477.28 | 14.01 | 0.88 |
| Vaishali Pharma Ltd | 12.12 | -5.90 | 606.00 | 246.01 | 2.31 | 0.00 |
| Astec Lifesciences Ltd | 653.90 | -5.55 | 0.00 | 450.03 | -239.30 | 0.00 |
Company Info
Artemis Health Institute, established in 2007, is a healthcare venture launched by the promoters of the Apollo Tyres Group. Artemis is the first Hospital in Gurgaon to get accredited by Joint Commission International (JCI) (in 2013). It is the first Hospital in Haryana to get NABH accreditation within 3 years of start up. 2016 -Patient safety award at International Patient safety conference. 2017 -Healthcare Transformation Awards Mobile Innovations in healthcare. -Best Hospital in Quality Treatment - State Health Awards. 2018 -FICCI Healthcare Excellence Award 2018 for Service Excellence. -Award for Excellence in Healthcare. 2019 -Kayakalp Award for Excellence in promoting cleanliness , hygiene and infection control. 2020 -First position in CII National HR Circle Competition. 2021 The Company has splits its face value from Rs. 10/- to Rs. 1
Artemis Health Institute, established in 2007, is a healthcare venture launched by the promoters of the Apollo Tyres Group. Artemis is the first Hospital in Gurgaon to get accredited by Joint Commission International (JCI) (in 2013). It is the first Hospital in Haryana to get NABH accreditation within 3 years of start up. 2016 -Patient safety award at International Patient safety conference. 2017 -Healthcare Transformation Awards Mobile Innovations in healthcare. -Best Hospital in Quality Treatment - State Health Awards. 2018 -FICCI Healthcare Excellence Award 2018 for Service Excellence. -Award for Excellence in Healthcare. 2019 -Kayakalp Award for Excellence in promoting cleanliness , hygiene and infection control. 2020 -First position in CII National HR Circle Competition. 2021 The Company has splits its face value from Rs. 10/- to Rs. 1
Read More
Parent Organisation
Artemis Medicare Services Ltd.
Founded
18/05/2004
Managing Director
Dr.(Mrs.)Devlina Chakravarty
NSE Symbol
ARTEMISMEDEQ
FAQ
The current price of Artemis Medicare Services Ltd is ₹ 229.68.
The 52-week high for Artemis Medicare Services Ltd is ₹ 236.60 and the 52-week low is ₹ 225.35.
The market capitalization of Artemis Medicare Services Ltd is currently ₹ 3160.45. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Artemis Medicare Services Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Artemis Medicare Services Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Artemis Medicare Services Ltd shares.
The CEO of Artemis Medicare Services Ltd is Dr.(Mrs.)Devlina Chakravarty, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
